Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
Proof of Concept (PoC) successfully provides primary packaging with a unique ID to access its own trustworthy digital twin Users gain immediate access to quality and process data of products…